Customized laser epithelial removal and corneal collagen cross-linking for keratoconus: the Tel-Aviv protocol

Session Details

Session Title: Moderated Poster Session: Refractive
Session Date/Time: Saturday 16/02/2019 | 14:00-15:00
Paper Time: 14:24
Venue: Poster Area


First Author: M.Mimouni ISRAEL
Co Author(s): G. Rabina  I. Kaiserman              

Abstract Details

Purpose:

To present the Tel-Aviv protocol for progressive keratoconus (KC) patients, customized laser epithelial removal (CLR) combined with corneal collagen cross linking (CXL).

Setting:

Care-Vision Laser Centers, Tel-Aviv, Israel

Methods:

Ten consecutive patients diagnosed with progressing KC at Care-Vision Laser Centers, Tel-Aviv, Israel. All patients underwent CLR-CXL. Data collected included, thinnest corneal thickness (TCT), subjective sphere, spherical equivalent and astigmatism, mean keratometric power, minimum keratometric power (Kmin), maximum keratometric power (Kmax), uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA) of both eyes.

Results:

A total of 10 eyes of 10 patients with a mean age of 31.10±4.31 years and a mean follow-up of 770±269.7 days were included. There was a significant improvement in both UCVA (1.00±0.71 logMAR to 0.20±0.08 logMAR, p=0.007) and BCVA (from 0.20±0.12 logMAR to 0.11±0.08 logMAR, p=0.003). There was a significant improvement in mean keratometry (46.62±1.85D to 44.68±1.86D, p<0.001) and Kmax (47.84±2.34D to 45.70±2.29D, p<0.001). Central corneal thickness was significantly lower following the procedure (from 446.8±43.0μm to 399.1±57.2μm, p=0.001). No complications or progression occurred.

Conclusions:

The Tel-Aviv protocol for progressive KC patients, provides good improvement in visual acuity and astigmatism while the progression of KC halting.

Financial Disclosure:

None